Study of Hepatitis B Virus Variants from Patients During the Treatment with Polymerase Inhibitors
碩士 === 國立成功大學 === 分子醫學研究所 === 92 === Chronic infection of hepatitis B virus (HBV) is considered as an increasing risk factor developing cirrhosis and hepatocellular carcinoma. In the treatment of chronic hepatitis B patients, the use of lamivudine is effective to suppress viral replication; howev...
Main Authors: | Stevie Lai, 賴冠瑜 |
---|---|
Other Authors: | Ting-Tsung Chang |
Format: | Others |
Language: | en_US |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/95178594888201662231 |
Similar Items
-
In Silico Screening Hepatitis B Virus DNA Polymerase Inhibitors from Medicinal Plants
by: Mokhtar Nosrati, et al.
Published: (2017-08-01) -
Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
by: Megan H. Powdrill, et al.
Published: (2010-09-01) -
Inhibitors of the hepatitis C virus RNA-dependent RNA polymerase
by: Barbara Attenni, et al.
Published: (2006-03-01) -
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
by: Auda A. Eltahla, et al.
Published: (2015-09-01) -
Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)